Results 111 to 120 of about 18,744,545 (170)

Additional file 1 of Evaluation of the impact of low activity imaging in [11C]-(+)-PHNO and [11C]UCB-J PET-MR scans

Supplementary Material 1.
Ribeiro, Daniela, Hallett, William, Howes, Oliver, McCutcheon, Robert, Nour, Matthew M., Nutt, David, Erritzoe, David, Agnorelli, Claudio, Husbands, Stephen   +8 more
openaire   +1 more source

Simplified Quantification of ¹¹C-UCB-J PET Evaluated in a Large Human Cohort. [PDF]

J Nucl Med, 2021
Naganawa M, Gallezot JD, Finnema SJ, Matuskey D, Mecca A, Nabulsi NB, Labaree D, Ropchan J, Malison RT, D'Souza DC, Esterlis I, Detyniecki K, van Dyck CH, Huang Y, Carson RE.   +14 more
europepmc   +1 more source

Associations between fluid biomarkers and PET imaging ([11C]UCB-J) of synaptic pathology in Alzheimer's disease. [PDF]

Alzheimers Dement
Nilsson J, Mecca AP, Ashton NJ, Salardini E, O'Dell RS, Carson RE, Benedet AL, Blennow K, Zetterberg H, van Dyck CH, Brinkmalm A.   +10 more
europepmc   +1 more source

Comparison of [¹¹C]UCB-J and [¹⁸F]FDG PET in Alzheimer's disease: A tracer kinetic modeling study. [PDF]

J Cereb Blood Flow Metab, 2021
Chen MK, Mecca AP, Naganawa M, Gallezot JD, Toyonaga T, Mondal J, Finnema SJ, Lin SF, O'Dell RS, McDonald JW, Michalak HR, Vander Wyk B, Nabulsi NB, Huang Y, Arnsten AF, van Dyck CH, Carson RE.   +16 more
europepmc   +1 more source

Lower prefrontal cortical synaptic vesicle binding in cocaine use disorder: An exploratory ¹¹ C-UCB-J positron emission tomography study in humans. [PDF]

Addict Biol, 2022
Angarita GA, Worhunsky PD, Naganawa M, Toyonaga T, Nabulsi NB, Li CR, Esterlis I, Skosnik PD, Radhakrishnan R, Pittman B, Gueorguieva R, Potenza MN, Finnema SJ, Huang Y, Carson RE, Malison RT.   +15 more
europepmc   +1 more source

Kinetics and 28-day test-retest repeatability and reproducibility of [¹¹C]UCB-J PET brain imaging. [PDF]

J Cereb Blood Flow Metab, 2021
Tuncel H, Boellaard R, Coomans EM, de Vries EF, Glaudemans AW, Feltes PK, García DV, Verfaillie SC, Wolters EE, Sweeney SP, Ryan JM, Ivarsson M, Lynch BA, Schober P, Scheltens P, Schuit RC, Windhorst AD, De Deyn PP, van Berckel BN, Golla SS.   +19 more
europepmc   +1 more source

Exploring the influence of synaptic density and anxiety on pain perception: evidence from a [11C]UCB-J positron emission tomography imaging study. [PDF]

Int J Neuropsychopharmacol
Moisieienko K, Asch RH, Davis MT, Pietrzak RH, Esterlis I.   +4 more
europepmc   +1 more source

Optimized reference region and the effect on test-retest reliability and sensitivity to differences between Parkinson's disease and control groups with [¹¹C]UCB-J. [PDF]

J Cereb Blood Flow Metab
Khattar N, Matuskey D, Gallezot JD, Naganawa M, Holmes SE, Ebrahimian Sadabad F, Mayeli M, Esterlis I, van Dyck CH, Mecca AP, D'Souza DC, Nabulsi NB, Finnema SJ, Huang Y, Carson RE, Toyonaga T.   +15 more
europepmc   +1 more source

HIV-1 Tat expression drives progressive synaptic decline: evidence from longitudinal [¹¹C]-UCB-J PET imaging. [PDF]

NeuroImmune Pharm Ther
Yadav TC, Orsucci IC, Thompson SV, Wu Z, Li Z, Yuan H, Yadav-Samudrala BJ, Fitting S.   +7 more
europepmc   +1 more source

Whole brain grey matter synaptic terminal density, age and intellectual functioning in schizophrenia: an in vivo [¹¹C]UCB-J positron emission tomography study. [PDF]

Neuropsychopharmacology
Onwordi EC, Whitehurst T, Shatalina E, Mansur A, Arumuham A, Osugo M, Marques TR, Jauhar S, Mehrotra R, Ranger M, Rahaman N, Church SM, Rabiner EA, Gunn RN, Natesan S, Reichenberg A, Howes OD.   +16 more
europepmc   +1 more source